Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Definitive Healthcare Corp. - Class A Common Stock (NQ: DH )

2.590 -0.160 (-5.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Definitive Healthcare Corp. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices 
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing 
From Definitive Healthcare Corp.
Via GlobeNewswire
Expert Outlook: Definitive Healthcare Through The Eyes Of 4 Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Definitive Healthcare
Via Benzinga
Definitive Healthcare Publishes 2023 Sustainability Report
Second annual report showcases Definitive Healthcare’s continued successes related to culture, governance, and the environment 
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise 
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Definitive Healthcare
Via Benzinga
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
From Definitive Healthcare Corp.
Via GlobeNewswire
5 Medical Info Systems Stocks To Buy For Stable Returns
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets
Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable
Definitive Healthcare reports Q1 adjusted EPS of $0.08, sales at $63.48M, and adjusted EBITDA of $20 million. Q2 revenue guidance: $62–$63.5 million. FY 2024 revenue outlook: $255–$261 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
DH Stock Earnings: Definitive Healthcare Meets EPS, Misses Revenue for Q1 2024
DH stock results show that Definitive Healthcare met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024
First quarter revenue grew 7% year-over-year to $63.5 million 
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry
Medtech commercial teams can now solve frontline sales challenges with exceptional data and streamlined workflows 
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
From Definitive Healthcare Corp.
Via GlobeNewswire
Challenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 Analysis
Definitive Healthcare's Q4 2023 performance, with adjusted EPS at $0.07, sales of $65.93 million, and a 5% Y/Y growth in enterprise clients. Get insights into Q1 2024 guidance and fiscal year 2024... 
Via Benzinga
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Draws Contrasting Analyst Views After CEO Resigns: One Downgrades, Another Is Optimistic
Definitive Healthcare undergoes leadership change. Interim CEO appointed; financial guidance reaffirmed for Q4 2023. 
Via Benzinga
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan... 
Via Benzinga
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Definitive Healthcare Announces CEO Transition
From Definitive Healthcare Corp.
Via GlobeNewswire
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
From Definitive Healthcare Corp.
Via GlobeNewswire
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.